FDA panel agrees with kidney warning on certain gadolinium contrast dyes - TheHeart.Org PDF Print
TheHeart.OrgThe aim of yesterday's meeting of the FDA's Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees was to review data from ...Link between nephrogenic systemic fibrosis, gadolinium-based contrast agents

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.